Global Angina Market, By Drug Class (Beta Blockers, Nitrates and Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Others), Types (Stable Angina and Unstable Angina, Variant (Prinzmetal) Angina and Microvascular Angina), End User (Hospitals, Cardiology Centers and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Angina
Angina market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 5.90% in the above-mentioned forecast period.
Angina pectoris is basically a chest pain or discomfort caused due to coronary heart disease. The angina pectoris occurs when the heart muscle does not receive enough oxygen or when one or more of the heart's arteries is narrowed or blocked, a condition known as ischemia. They are cured using various drugs such as beta blockers, nitrates and calcium channel blockers, angiotensin-converting enzyme inhibitors and others.
The development of biosimilars and biobetters, increase in diabetic and hypertension population due to bad lifestyle and increase in consumption of alcohol and smoking are the significant factors responsible for driving the growth of the angina market in the above-mentioned forecast period. Additionally, the growing investments and spending by consumers in healthcare along with the rising prevalence and incidence of angina pectoris also heighten the overall growth of the market. However, the downward pricing pressure owing to its commodity nature obstruct the market’s growth. The high cost for surgical procedures like coronary bypass surgery is expected to hamper the overall growth of the market.
The various technological advances in personalized cardiovascular medicine as well as the enhancement of innovative drug delivery systems are expected to generate profitable opportunities for the market. On the other hand, the increased use of minimally invasive surgeries and shortage of skilled professional have the potential to challenge for the market’s growth.
This angina market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research angina market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Angina Market Scope and Market Size
Angina market is segmented on the basis of drug class, types and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on drug class, the angina market is segmented into beta blockers, nitrates and calcium channel blockers, angiotensin-converting enzyme inhibitors and others. Drug class are further classified into nitrates, anti-anginal, and ACE inhibitors.
- On the basis of types, the angina market is segmented into stable angina and unstable angina, variant (prinzmetal) angina and microvascular angina.
- Based on end-users, the angina market is segmented into hospitals, cardiology centers and others.
Angina Market Country Level Analysis
Angina market is analyzed and market size insights and trends are provided by drug class, types and end user as referenced above.
The countries covered in the angina market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to well-developed healthcare sector, growing healthcare expenditure and a huge patient population for coronary heart diseases. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the presence of developing economies such as India and China and a developing healthcare sector.
The country section of the angina market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Angina market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for angina market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the angina market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Angina Market Share Analysis
Angina market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to angina market.
Some of the major players operating in the angina market report are Sanofi, Gilead Sciences, Inc., AstraZeneca, Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd. Bristol-Myers Squibb Company, Bayer AG, Abbott, Saneron CCEL Therapeutics, Inc. Vasomedical, Inc, Cryopraxis Ltda, Neovasc Inc., and LUMITOS AG, among others.
SKU-